Fed Circuit Watch: No Standing to Appeal When Biosimilar Product Withdrawn
Sometimes substantive patent issues are never dealt with in cases, but rather dispositive issues are handled by procedural mechanisms. One case in point is Momenta Pharms., Inc. v. Bristol-Myers...
Fed Circuit Watch: District Courts Still Have Problems with Cray Rule
On February 5, 2019, the Court of Appeals for the Federal Circuit denied a petition for writ of mandamus, with a combined petition for rehearing and/or rehearing en banc, in In re Google LLC, the...
Fed Circuit Watch: Walker Process Case Denied En Banc Review
On June 15, 2018, an expanded panel of the Court of Appeals for the Federal Circuit denied petitions for rehearing and rehearing en banc in a per curiam order. This case is Xitronix Corp. v....
IP & Nonhumans: Lessons of Naruto the Monkey on AI
A particular copyright case, although not dealing directly with technology, has fingerprints that lead to one area of technology that shares some legal issues with animals: artificial intelligence....
Fed Circuit Watch: Fed Circuit Lacks Jurisdiction to Review Antitrust Claim
On February 9, 2018, the Court of Appeals for the Federal Circuit issued a short order refusing jurisdiction over a Walker Process antitrust claim, and transferred the case, Xitronix Corp. v....
No posts found
Try adjusting your filters